Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial.

Tadakazu Hisamatsu,Mamoru Watanabe,Noriko Kamata,Hirofumi Michimae,Hiroshi Nakase,Kenji Watanabe,Reiko Kunisaki,Makoto Naganuma,Takanori Kanai,Fumihito Hirai,Akira Andoh,Toshifumi Hibi,Masakazu Nagahori,Yasuo Suzuki,Tomoyuki Tsujikawa,Shinji Tanaka,Akihiro Yamada,Tadashi Yokoyama,Keitaro Yokoyama ,Shirô Nakamura

doi:10.5217/ir.2018.16.3.494

Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial.

Tadakazu Hisamatsu, Mamoru Watanabe + Show 18 more

Open Access

https://doi.org/10.5217/ir.2018.16.3.494

Copy DOI

Journal: Intestinal Research	Publication Date: Jan 1, 2018
Citations: 22	License type: CC BY-NC 4.0

Affiliation: Kyorin University, Tokyo Medical and Dental University, Osaka City University, Kitasato University, Sapporo Medical University, Hyogo Medical University, Yokohama City University Medical Center, Yokohama City University, Keio University, Fukuoka University, Shiga University of Medical Science, Kitasato Institute Hospital, Toho University, Toho University Medical Center Sakura Hospital, National Hospital Organization, Hiroshima University Hospital

#Infliximab Dose Escalation #Escalation In Patients + Show 4 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial.

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Intestinal Research

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.